Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6547 stock hub

TPEX/6547 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6547is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6547

In the news

Latest news · TPEX/6547

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E127.8

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-7.7

P25 -16.2P50 0.3P75 9.8

ROIC-4.2

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6547 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

TWD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	103
Employees Change	15%
Employees Change Percent	17.05
Enterprise value	TWD 14.5B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006547003
Last refreshed	2026-05-10
Market cap	TWD 16B
Price	TWD 48.55
Price currency	TWD
Rev Per Employee	5,953,116.5x
Sector	Healthcare
Sic	2836
Symbol	tpex/6547
Website	https://www.medigenvac.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.77%
EV Earnings	-51.37x
EV/FCF	-145.13x
EV/Sales	23.6x
FCF yield	-0.62%
Forward P/E	127.76x
P/B ratio	4.59x
P/S ratio	26.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-43.33%
EBITDA Margin	-23.52%
Gross margin	59.47%
Gross Profit	TWD 364.7M
Gross Profit Growth	-8.01%
Gross Profit Growth Q	48.09%
Gross Profit Growth5 Y	116.67%
Net Income	TWD -281.7M
Net Income Growth Years	0%
Pretax Margin	-45.94%
Profit Margin	-45.94%
Profit Per Employee	TWD -2.7M
ROA	-4
Roa5y	-3.7
ROCE	-7.09
ROE	-7.69
Roe5y	-6.04
ROIC	-4.18

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.36%
Cagr1y	-0.92%
Cagr3y	-9.5%
Cagr5y	-23.46%
EPS Growth Years	0
FCF Growth Q	-42.28%
OCF Growth Q	-41.97%
Revenue Growth	1.24x
Revenue Growth Q	14.14x
Revenue Growth Quarters	1x
Revenue Growth Years	3x
Revenue Growth3 Y	18.87x
Revenue Growth5 Y	121.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.15
Assets	TWD 3.9B
Cash	TWD 1.8B
Current Assets	TWD 2.4B
Current Liabilities	TWD 185M
Debt	TWD 283.4M
Debt Equity	TWD 0.08
Debt FCF	TWD -2.84
Equity	TWD 3.5B
Interest Coverage	-30.19
Liabilities	TWD 454.6M
Long Term Assets	TWD 1.6B
Long Term Liabilities	TWD 269.6M
Net Cash	TWD 1.5B
Net Cash By Market Cap	TWD 9.33
Net Cash Growth	-5.58%
Net Debt Equity	TWD -0.43
Tangible Book Value	TWD 3.5B
Tangible Book Value Per Share	TWD 10.52
WACC	4.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.77
Inventory Turnover	0.59
Net Working Capital	TWD 419.5M
Quick ratio	10.35
Working Capital	TWD 2.2B
Working Capital Turnover	TWD 0.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	144.57%
1Y total return	-0.92%
200-day SMA	40.71
3Y total return	-25.88%
50-day SMA	47.19
50-day SMA vs 200-day SMA	50over200
5Y total return	-73.73%
All Time High	281.2
All Time High Change	-82.74%
All Time High Date	2021-05-17
All Time Low	16.19
All Time Low Change	199.95%
All Time Low Date	2015-10-28
ATR	2.19
Beta	-0.03
Beta1y	-0.63
Beta2y	0.01
Ch YTD	28.61
High	49.95
High52	61.2
High52 Date	2026-04-09
High52ch	-20.67%
Low	48
Low52	33.5
Low52 Date	2025-11-06
Low52ch	44.93%
Ma50ch	2.88%
Price vs 200-day SMA	19.26%
RSI	47.48
RSI Monthly	48.95
RSI Weekly	59.73
Sharpe ratio	0.12x
Sortino ratio	0.34
Total Return	-0.03%
Tr YTD	28.61
Tr1m	-18.13%
Tr1w	-2.71%
Tr3m	33.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -265.7M
Operating margin	-43.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	253,939,620%
Net Borrowing	-39,186,000
Shares Insiders	0.28%
Shares Institutions	2.66%
Shares Out	328,749,050
Shares Qo Q	0%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -130.7M
Average Volume	3,175,269.55x
Bv Per Share	10.58
CAPEX	TWD -50.6M
Ch10y	130.8
Ch1m	-18.13
Ch1w	-2.71
Ch1y	-0.92
Ch3m	33.2
Ch3y	-25.88
Ch5y	-73.82
Ch6m	30.86
Change	0.41%
Change From Open	1.15
Close	48.35
Days Gap	-0.72
Depreciation Amortization	121,485,000
Dollar Volume	83,817,205.5
Earnings Date	2026-05-15
EBIT	TWD -265.7M
EBITDA	TWD -144.2M
EPS	TWD -0.86
F Score	3
FCF	TWD -99.7M
FCF EV Yield	-0.69x
FCF Per Share	TWD -0.3
Financing CF	-39,186,000
Fiscal Year End	December
Founded	2,012
Investing CF	-35,303,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2022-08-03
Last Split Type	Forward
Ma150	40.85
Ma150ch	18.86%
Ma20	49.5
Ma20ch	-1.91%
Net CF	-123,576,000
Next Earnings Date	2026-05-15
Open	48
Position In Range	28.21
Ppne	1,244,111,000
Price Date	2026-05-08
Ptbv Ratio	4.62
Relative Volume	0.53x
Revenue	613,171,000x
SBC By Revenue	5.06x
Share Based Comp	31,005,000
Tr6m	30.86%
Volume	1,726,410
Z Score	19.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6547 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6547 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6547?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.7%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

TPEX/6547 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.5

Neutral momentum band

Price vs 200-day MA

+19.3%

50/200-day relationship not available

Beta (5Y)

-0.03

Less volatile than the market

Sharpe ratio

0.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6547

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6547 stock rating?

tpex/6547 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6547 analysis?

The full report lives at /stocks/tpex/6547/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6547?

The latest report frames tpex/6547 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6547 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.